These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 31241925)

  • 1. Organometallic Titanocene-Gold Compounds as Potential Chemotherapeutics in Renal Cancer. Study of their Protein Kinase Inhibitory Properties.
    Fernández-Gallardo J; Elie BT; Sulzmaier FJ; Sanaú M; Ramos JW; Contel M
    Organometallics; 2014 Nov; 33(22):6669-6681. PubMed ID: 25435644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, anticancer activity, and molecular docking of half-sandwich iron(II) cyclopentadienyl complexes with maleimide and phosphine or phosphite ligands.
    Das S; Strachanowska M; Wadowski P; Juszczak M; Tokarz P; Kosińska A; Palusiak M; Rybarczyk-Pirek AJ; Wzgarda-Raj K; Vasudevan S; Chworos A; Woźniak K; Rudolf B
    Sci Rep; 2024 Mar; 14(1):5634. PubMed ID: 38454122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Antiproliferative Properties of CpRu Complexes Containing N-Methylated Triazaphosphaadamantane Derivatives.
    Alguacil A; Scalambra F; Romerosa A; Bento-Oliveira A; Marques F; Maximiano I; de Almeida RFM; Tomaz AI; Valente A
    Bioinorg Chem Appl; 2023; 2023():6669394. PubMed ID: 37808953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Ruthenium-Cyclopentadienyl Complexes Affect Colorectal Cancer Hallmarks Showing High Therapeutic Potential.
    Brás AR; Fernandes P; Moreira T; Morales-Sanfrutos J; Sabidó E; Antunes AMM; Valente A; Preto A
    Pharmaceutics; 2023 Jun; 15(6):. PubMed ID: 37376178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergy of ruthenium metallo-intercalator, [Ru(dppz)
    Yusoh NA; Chia SL; Saad N; Ahmad H; Gill MR
    Sci Rep; 2023 Jan; 13(1):1456. PubMed ID: 36702871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biotinylated Polymer-Ruthenium Conjugates: In Vitro and In Vivo Studies in a Triple-Negative Breast Cancer Model.
    Côrte-Real L; Brás AR; Pilon A; Mendes N; Ribeiro AS; Martins TD; Farinha JPS; Oliveira MC; Gärtner F; Garcia MH; Preto A; Valente A
    Pharmaceutics; 2022 Jun; 14(7):. PubMed ID: 35890283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ruthenium(II)-Cyclopentadienyl-Derived Complexes as New Emerging Anti-Colorectal Cancer Drugs.
    Teixeira-Guedes C; Brás AR; Teixeira RG; Valente A; Preto A
    Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ruthenium carboranyl complexes with 2,2'-bipyridine derivatives for potential bimodal therapy application.
    Teixeira RG; Marques F; Robalo MP; Fontrodona X; Garcia MH; Geninatti Crich S; Viñas C; Valente A
    RSC Adv; 2020 Apr; 10(28):16266-16276. PubMed ID: 35498822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the In Vitro and In Vivo Efficacy of Ruthenium Polypyridyl Compounds against Breast Cancer.
    Lenis-Rojas OA; Roma-Rodrigues C; Fernandes AR; Carvalho A; Cordeiro S; Guerra-Varela J; Sánchez L; Vázquez-García D; López-Torres M; Fernández A; Fernández JJ
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, structure and anticancer properties of new biotin- and morpholine-functionalized ruthenium and osmium half-sandwich complexes.
    Marloye M; Inam H; Moore CJ; Debaille V; Pritchard JR; Gelbcke M; Meyer F; Dufrasne F; Berger G
    J Biol Inorg Chem; 2021 Aug; 26(5):535-549. PubMed ID: 34173882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging Molecular Receptors for the Specific-Target Delivery of Ruthenium and Gold Complexes into Cancer Cells.
    Machado JF; Correia JDG; Morais TS
    Molecules; 2021 May; 26(11):. PubMed ID: 34070457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the Potential of Metallodrugs as Chemotherapeutics for Triple Negative Breast Cancer.
    Nayeem N; Contel M
    Chemistry; 2021 Jun; 27(35):8891-8917. PubMed ID: 33857345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticancer Activity and In Vitro to In Vivo Mechanistic Recapitulation of Novel Ruthenium-Based Metallodrugs in the Zebrafish Model.
    Karas BF; Hotz JM; Gural BM; Terez KR; DiBona VL; Côrte-Real L; Valente A; Buckley BT; Cooper KR
    Toxicol Sci; 2021 Jul; 182(1):29-43. PubMed ID: 33822233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A New Family of Iron(II)-Cyclopentadienyl Compounds Shows Strong Activity Against Colorectal and Triple Negative Breast Cancer Cells.
    Pilon A; Brás AR; Côrte-Real L; Avecilla F; Costa PJ; Preto A; Garcia MH; Valente A
    Molecules; 2020 Mar; 25(7):. PubMed ID: 32235674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological assessment of a ruthenium(II) cyclopentadienyl complex in breast cancer cells and on the development of zebrafish embryos.
    Golbaghi G; Pitard I; Lucas M; Haghdoost MM; de Los Santos YL; Doucet N; Patten SA; Sanderson JT; Castonguay A
    Eur J Med Chem; 2020 Feb; 188():112030. PubMed ID: 31945643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationally Designed Ruthenium Complexes for Breast Cancer Therapy.
    Golbaghi G; Castonguay A
    Molecules; 2020 Jan; 25(2):. PubMed ID: 31936496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel screening method for transition metal-based anticancer compounds using zebrafish embryo-larval assay and inductively coupled plasma-mass spectrometry analysis.
    Karas BF; Côrte-Real L; Doherty CL; Valente A; Cooper KR; Buckley BT
    J Appl Toxicol; 2019 Aug; 39(8):1173-1180. PubMed ID: 30963621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ruthenium-Cyclopentadienyl Bipyridine-Biotin Based Compounds: Synthesis and Biological Effect.
    Côrte-Real L; Karas B; Brás AR; Pilon A; Avecilla F; Marques F; Preto A; Buckley BT; Cooper KR; Doherty C; Garcia MH; Valente A
    Inorg Chem; 2019 Jul; 58(14):9135-9149. PubMed ID: 31241925
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.